Sexually Transmitted Infections
Gonorrhoea is caused by the bacteria Neisseria gonorrhoeae, which has progressively developed resistance to globally recommended treatments and has been identified by the World Health Organization as a priority infection urgently requiring new antibiotics. To address the lack of effective drugs, the Global Antibiotic Research and Development Partnership (GARDP) is developing a new treatment for gonorrhoea and is working to ensure it is available to everyone who needs it, wherever they live.
The country, countries or regions that benefit from this Programme.
The current stage of the Programme, consistent with the International Aid Transparency Initiative's (IATI) classifications.
Programme budget and spend to date, as per the amounts loaded in financial system(s), and for which procurement has been finalised.
Help with participating organisations
- Global Antibiotic Research and Development Partnership
Sector groups as a percentage of total Programme budget according to the OECD Development Assistance Committee (DAC) classifications.
A comparison across financial years of forecast budget and spend to date on the Programme.